Displaying results 133 - 144 of 176
General Hepatology
HK3, a novel MASH drug with profound anti-obesity action

HK3, a novel MASH drug with profound anti-obesity action

ePosters
View
General Hepatology
The vitamin E conundrum: Should you still be using it for metabolic dysfunction-associated steatotic liver disease (MASLD)

The vitamin E conundrum: Should you still be using it for metabolic dysfunction-associated steatotic liver disease (MASLD)

ePosters
View
General Hepatology
Microvascular complications of type 2 diabetes mellitus in patients with concomitant metabolic dysfunction-associated steatotic liver disease in primary care, a prospective cohort study

Microvascular complications of type 2 diabetes mellitus in patients with concomitant metabolic dysfunction-associated steatoti...

ePosters
View
General Hepatology
A serial investigation to develop herbal-derived therapeutics targeting MASLD and metabolic syndrome using Amomum Xanthioides

A serial investigation to develop herbal-derived therapeutics targeting MASLD and metabolic syndrome using Amomum Xanthioides

ePosters
View
General Hepatology
Paving the way for MASH screening of high-risk patients in primary and secondary care

Paving the way for MASH screening of high-risk patients in primary and secondary care

ePosters
View
General Hepatology
The dietitians role in the pre-operative workup for patients undergoing laparoscopic surgery of the upper GIT

The dietitians role in the pre-operative workup for patients undergoing laparoscopic surgery of the upper GIT

ePosters
View
General Hepatology
FLAME model: validation of a tool incorporating alpha-glutathione-s-transferase serum levels for predicting advanced fibrosis and cardiovascular events in MASLD

FLAME model: validation of a tool incorporating alpha-glutathione-s-transferase serum levels for predicting advanced fibrosis ...

ePosters
View
General Hepatology
Cholesterol exacerbates the pathophysiology of metabolic dysfunction-associated steatohepatitis by upregulating Hypoxia-Inducible Factor 1 and modulating microcirculatory dysfunction

Cholesterol exacerbates the pathophysiology of metabolic dysfunction-associated steatohepatitis by upregulating Hypoxia-Induci...

ePosters
View
General Hepatology
Normal fibrosis-4 values do not exclude advanced fibrosis in 15 of patients with metabolic dysfunction-associated steatotic liver disease

Normal fibrosis-4 values do not exclude advanced fibrosis in 15 of patients with metabolic dysfunction-associated steatotic li...

ePosters
View
General Hepatology
A randomized controlled study of daily aspirin to reduce fibrosis progression in metabolic dysfunction-associated steatotic liver disease

A randomized controlled study of daily aspirin to reduce fibrosis progression in metabolic dysfunction-associated steatotic li...

ePosters
View
General Hepatology
Fibrinolytic activity of blood plasma in pregnant women with MASH against various degrees of obesity

Fibrinolytic activity of blood plasma in pregnant women with MASH against various degrees of obesity

ePosters
View
General Hepatology
Liver fibrosis in the elderly: Prevalence and association with cognitive function in the Whitehall II study

Liver fibrosis in the elderly: Prevalence and association with cognitive function in the Whitehall II study

ePosters
View
Displaying results 133 - 144 of 176